## Abstract Monocytes from the peripheral blood of 10 normal adult human donors were tested for their cytolytic activity on untransformed or SV40‐transformed, early passage, human fibroblasts. Two pairs of human fibroblast lines (2303 and SV40–2303, 2931 and SV40–2931) were used and lysis was asses
Cytolytic and cytostatic activity on tumor cells of circulating human monocytes
✍ Scribed by Alberto Mantovani; Thomas R. Jerrells; Jack H. Dean; Ronald B. Herberman
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- French
- Weight
- 980 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Monocytes from the peripheral blood of normal adult human donors were found to have appreciable levels of cytotoxic activity against murine and human tumor‐cell lines. Adherent cells ( > 90% monocytes) were obtained from the peripheral blood of 29 normal healthy volunteers either by adherence on plastic and scraping with a rubber policeman or by adherence on microexudate‐coated plastic and exposure to ethylene diamine tetra‐acetic acid. Cytolytic capacity was tested by incubating effector cells for 72 h with murine and human tumor cell lines prelabelled with tritiated thy‐midine. Cytostasis was evaluated by inhibition of [^125^I]iododeoxyuridine (^125^IdUrd) uptake. Tumor target cells employed were: a murine SV40‐trans‐formed kidney line (TU5), a murine chemically‐induced sarcoma (1023), a human breast‐cancer‐derived cell line (G11) and a human lung‐cancer‐derived cell line (CaLu). Monocyte preparations at attacker to target cell ratios of 1:1 to 40:1, showed significant cytolytic and cytostatic activity against tumor target cells. Tumor cells showed different susceptibility to cytolytic activity, whereas comparable levels of cytostasls were observed with the various targets: TU5 and G11 tumor cells were more susceptible than 1023 and CaLu target cells to the cytolytic capacity of human monocytes and TU5 was used in most subsequent experiments. Peak isotope release from prelabelled target cells was observed after 72 h of incubation, whereas peak inhibition of [^125^I]dUrd uptake occurred after 24 h of culture. The cytotoxic capacity of monocytes isolated by either of the two methods mentioned above was similar. The monocytes had higher cytotoxic activity than unseparated mononuclear cells, and non‐adherent cells showed minimal cytotoxic effects. Cytotoxicity by natural killer cells did not appear to have a major role in these assays, since adherent cells did not lyse K562 cells in a 4‐h ^51^Cr release assay. Treatment with anti‐human T‐cell serum and complement did not inhibit the cytotoxic capacity of the monocyte preparations, whereas exposure to silica particles significantly inhibited the cytotoxic activity. Monocyte‐mediated cytotoxicity on tumor cells was expressed in the presence of both fetal bovine serum and human AB serum.
📜 SIMILAR VOLUMES
## Abstract We investigated the capacity of 3 major cytokines secreted by activated monocytes, IL‐1β, TNFα and IL‐6, to inhibit growth of melanoma tumor cells. Using neutralizing antibodies against IL‐1β, TNFα and IL‐6, we observed that the cytostatic activity against A375 melanoma cells is largely
## Abstract We have previously shown that a chimeric IgE antibody against the folic acid receptor (MOv18 IgE) inhibits tumor growth in a SCID mouse model of ovarian carcinoma. MOv18 IgE gave greater protection than the corresponding chimeric MOv18 IgG1. We have now confirmed these effects in a nude
## Abstract Ten species of purified human leukocyte interferon were tested for their ability to modulate the cytolytic activity of natural killer (NK) cells and the cytolytic and cytostatic activities of monocytes. The interferon species were tested at several antiviral tilers and examined for quan
## Abstract The antiproliferative activity of the chemotherapeutic agent taxol was evaluated on 2 normal and 2 carcinoma human breast‐cell lines and compared with its effects on newborn rat cardiac cells growing __in vitro__. Relatively little difference in ID~50~ response (ranging from 0.6 to 2.0
Polyethylene glycol (PEG 8000) is a potent cancer chemopreventive agent. This osmotic laxative polymer markedly suppresses colon cancer in rats. To explain the mechanism, we have tested the in vitro effect of PEG on four human cell lines. Two poorly differentiated adenocarcinoma lines (HT29 and COLO